TRMT61B has been shown to be differentially expressed in various tumor types, including gastric cancer [56] and highly aneuploid tumors [57], and is associated with poor clinical prognosis in gastric cancer patients[56]. This evidence concerns the gene TRMT61B and neoplasm.